In addition to its linkage with B-cell neoplasms, aberrant IκBα function was also detected in chronic myeloid leukemia (CML), a myeloproliferative disorder driven by the BCR-ABL translocation. Here, NFKBIA is linked to chronic myelogenous leukemia, BCR-ABL1 positive.